조현병 중증도와 염증 표지자(호중구/림프구 비율, 단핵구/림프구 비율, 혈소판/림프구 비율)의 연관성
Relationships Between Schizophrenia Severity and Inflammatory Biomarker: Neutrophil/Lymphocyte Ratio, Monocyte/Lymphocyte Ratio, Platelet/Lymphocyte Ratio
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), and platelet/lymphocyte ratio (PLR) are inflammatory biomarkers. Potential of these inflammatory biomarkers as state marker of schizophrenia severity is controversial. This study aimed to investigate the relationship between inflammatory biomarkers and schizophrenia severity. Methods: From January 2010 to June 2020, the medical records of schizophrenia patients admitted to Kosin University Gospel Hospital were retrospectively examined and 91 patients who met the inclusion criteria were selected as the subjects of the study. The Korean version of the Positive and Negative Syndrome Scale (PANSS-KV) was used to assess schizophrenia symptom severity and divided into PANSS-KV total score (PANSS-T), PANSS-KV positive syndrome subscale (PANSS-P), PANSS-KV negative syndrome subscale (PANSS-N), PANSS-KV general psychopathology subscale (PANSS-G). Results: In 91 subjects, 40 were male and 51 were female. We found no significant relationship between sex, age, number of hospitalization and NLR, MLR, PLR. Patients with higher NLR, MLR, PLR had higher PANSS-T scores. Positive correlation between NLR, MLR, PLR and PANSS-N, PANSS-G was demonstrated. There was no significant correlation between NLR, MLR, PLR and PANSS-P. Conclusions: We investigate the possibility of inflammatory biomarkers as state markers of schizophrenia symptom severity. A well-designed prospective study involving a larger cohort is needed in the future.
Abstract
Objectives: Neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), and platelet/lymphocyte ratio (PLR) are inflammatory biomarkers. Potential of these inflammatory biomarkers as state marker of schizophrenia severity is controversial. This study aimed to investigate the relationship between inflammatory biomarkers and schizophrenia severity. Methods: From January 2010 to June 2020, the medical records of schizophrenia patients admitted to Kosin University Gospel Hospital were retrospectively examined and 91 patients who met the inclusion criteria were selected as the subjects of the study. The Korean version of the Positive and Negative Syndrome Scale (PANSS-KV) was used to assess schizophrenia symptom severity and divided into PANSS-KV total score (PANSS-T), PANSS-KV positive syndrome subscale (PANSS-P), PANSS-KV negative syndrome subscale (PANSS-N), PANSS-KV general psychopathology subscale (PANSS-G). Results: In 91 subjects, 40 were male and 51 were female. We found no significant relationship between sex, age, number of hospitalization and NLR, MLR, PLR. Patients with higher NLR, MLR, PLR had higher PANSS-T scores. Positive correlation between NLR, MLR, PLR and PANSS-N, PANSS-G was demonstrated. There was no significant correlation between NLR, MLR, PLR and PANSS-P. Conclusions: We investigate the possibility of inflammatory biomarkers as state markers of schizophrenia symptom severity. A well-designed prospective study involving a larger cohort is needed in the future.
참고문헌 (34)
- McGrath J, "Schizophrenia: a concise overview of incidence, prevalence, and mortality", Epidemiol Rev, 30, pp.67~76 (2008)
- Müller N, "Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations", Schizophr Bull, 44, pp.973~982 (2018)
- Khandaker GM, "Inflammation and immunity in schizophrenia:implications for pathophysiology and treatment", Lancet Psychiatry, 2, pp.258~270 (2015)
- Tomasik J, "Neuroimmune biomarkers in schizophrenia", Schizophr Res, 176, pp.3~13 (2016)
- Mazza MG, "Cross-sectional study of neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in mood disorders", Gen Hosp Psychiatry, 58, pp.7~12 (2019)
- Liu J, "The correlation between PLR-NLR and prognosis in acute myocardial infarction", Am J Transl Res, 13, pp.4892~4899 (2021)
- Cheng HR, "High monocyte-to-lymphocyte ratio is associated with stroke-associated pneumonia", Front Neurol, 11, pp.575809~ (2020)
- Afari ME, "Neutrophil to lymphocyte ratio (NLR)and cardiovascular diseases: an update", Expert Rev Cardiovasc Ther, 14, pp.573~577 (2016)
- Min GT, "The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: a systematic review and meta-analysis", Clin Transplant, 32, pp.e13151~ (2018)
- Yang Z, "Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil- lymphocyte ratios among various systemic autoimmune rheumatic diseases", APMIS, 125, pp.863~871 (2017)
- Yao C, "Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD", Int J Chron Obstruct Pulmon Dis, 12, pp.2285~2290 (2017)
- Kuyumcu ME, "The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease", Dement Geriatr Cogn Disord, 34, pp.69~74 (2012)
- Sayed A, "The neutrophil-to-lymphocyte ratio in Alzheimer's disease: current understanding and potential applications", J Neuroimmunol, 349, pp.577398~ (2020)
- Su M, "Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and monocyte to lymphocyte ratio in depression: a meta-analysis", J Affect Disord, 308, pp.375~383 (2022)
- Özdin S, "A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients - a retrospective file review", Nord J Psychiatry, 71, pp.509~512 (2017)
- Özdin S, "Neutrophil", lymphocyte, platelet, lymphocyte ratios in different stages of schizophrenia, pp.Psychiatry Res, 2019[DOI]
- Semiz M, "Elevated neutrophil", lymphocyte ratio in patients with schizophrenia, 2014, pp.26, 220~225
- Yüksel RN, "High neutrophil-lymphocyte ratio in schizophrenia independent of infectious and metabolic parameters", Nord J Psychiatry, 72, pp.336~340 (2018)
- Sandberg AA, "Is elevated neutrophil count and neutrophil-to-lymphocyte ratio a cause or consequence of schizophrenia?—A scoping review", Front Psychiatry, 12, pp.728990~ (2021)
- 이중서, "한국판 양성 및 음성증후군 척도(Positive and Negative Syndrome Scale)의 신뢰도와 타당도", 신경정신의학, 40(6), pp.1090~1105 (2001), 대한신경정신의학회
- Kay SR, "The positive and negative syndrome scale (PANSS) for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
- Karageorgiou V, "Neutrophilto-lymphocyte ratio in schizophrenia: a systematic review and meta-analysis", Schizophr Res, 206, pp.4~12 (2019)
- Zhu X, "Neutrophil", lymphocyte, platelet, lymphocyte ratios in schizophrenia, pp.Australas Psychiatry, 2022[DOI]
- Balcioglu Yasin Hasan, "C-Reactive Protein", Albumin and Neutrophil, PSYCHIATRY INVESTIGATION, pp.2020, 17(9)[DOI]
- Gercek HG, "Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammation markers for early-onset schizophrenia", Bratisl Lek Listy, 124, pp.503~507 (2023)
- Tong Z, "The neutrophillymphocyte ratio is positively correlated with aggression in schizophrenia", Biomed Res Int, 2022, pp.4040974~ (2022)
- Kulaksizoglu B, "Relationship between neutrophil", lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia, 2016, pp.12, 1999~2005
- Kovács MÁ, "Elevated osteopontin and interferon gamma serum levels and increased neutrophil-to-lymphocyte ratio are associated with the severity of symptoms in schizophrenia", Front Psychiatry, 10, pp.996~ (2019)
- Šagud M, "The associations of neutrophil-lymphocyte, platelet-lymphocyte, monocytelymphocyte ratios and immune-inflammation index with negative symptoms in patients with schizophrenia", Biomolecules, 13, pp.297~ (2023)
- Sicras-Mainar A, "Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia", Neuropsychiatr Dis Treat, 11, pp.51~57 (2015)
- Kolaczkowska E, "Neutrophil recruitment and function in health and inflammation", Nat Rev Immunol, 13, pp.159~175 (2013)
- Shi C, "Monocyte recruitment during infection and inflammation", Nat Rev Immunol, 11, pp.762~774 (2011)
- Upthegrove R, "Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia", Curr Top Behav Neurosci, 44, pp.49~66 (2020)
- Kirkpatrick B, "Inflammation and schizophrenia", Schizophr Bull, 39, pp.1174~1179 (2013)